M

Molecular Data Inc
NASDAQ:MKD

Watchlist Manager
Molecular Data Inc
NASDAQ:MKD
Watchlist
Price: 0.0022 USD 10%
Updated: May 23, 2024

Molecular Data Inc
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Molecular Data Inc
Total Liabilities & Equity Peer Comparison

Comparables:
BABA
PDD
6618
3690
9618

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
M
Molecular Data Inc
NASDAQ:MKD
Total Liabilities & Equity
¥684.8m
CAGR 3-Years
22%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Alibaba Group Holding Ltd
NYSE:BABA
Total Liabilities & Equity
¥1.8T
CAGR 3-Years
1%
CAGR 5-Years
13%
CAGR 10-Years
32%
Pinduoduo Inc
NASDAQ:PDD
Total Liabilities & Equity
¥348.1B
CAGR 3-Years
30%
CAGR 5-Years
52%
CAGR 10-Years
N/A
JD Health International Inc
HKEX:6618
Total Liabilities & Equity
¥61.3B
CAGR 3-Years
12%
CAGR 5-Years
120%
CAGR 10-Years
N/A
Meituan
HKEX:3690
Total Liabilities & Equity
¥293B
CAGR 3-Years
21%
CAGR 5-Years
19%
CAGR 10-Years
N/A
JD.Com Inc
HKEX:9618
Total Liabilities & Equity
¥601.8B
CAGR 3-Years
13%
CAGR 5-Years
23%
CAGR 10-Years
37%

See Also

What is Molecular Data Inc's Total Liabilities & Equity?
Total Liabilities & Equity
684.8m CNY

Based on the financial report for Dec 31, 2020, Molecular Data Inc's Total Liabilities & Equity amounts to 684.8m CNY.

What is Molecular Data Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 3Y
22%

Over the last year, the Total Liabilities & Equity growth was 39%. The average annual Total Liabilities & Equity growth rates for Molecular Data Inc have been 22% over the past three years .